ORTHOPRESERVE, INC.

HENRICO, VA · Founded 2021 · Medtech · Private

Artificial meniscus implant, a composite material device designed to replace damaged meniscal tissue in the knee joint

Claim this profile

Follows are private to you and power your alerts

Updated · orthopreserve.com

Sector
Medtech
Headquarters
HENRICO, VA
Founded
2021
Latest Form D
$157K, Dec 2025
Total capital
$511K
Federal grants
$304K
1 award · 2023
Rank in peer group#2 of 542
Private capital raised
$207K
2 Form D · last Dec 2025
10 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
None on recordNo USPTO grants. Applications publish after 18 months.

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $511K$304K1st Form D$50K2nd Form D$157K
202320242025FEDERAL ↑EQUITY ↓Cumulative $511K$304K1st Form D$50K2nd Form D$157K

Latest events

  • Private capital raisedForm D · SEC · 2nd filing$157K
  • Private capital raisedForm D · SEC · 1st filing$50K
  • Federal grantHealth and Human S · Phase I · Pre-Clinical Assessment of a Minimally Invasive Meniscus Implant to Delay Arthritis$304K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

13months

from ORTHOPRESERVE, INC.’s first federal award to its first private round.

First federal award · Sep 2023
Health and Human S · $304K
First Form D · Oct 2024
$50K · 1st Form D
Awards before first raise
1 award

An association in public records, not a cause or a prediction.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#2 · top 1%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Jonathan SchwartzResearcherExecutive Officer, DirectorLinked by $304K in grants as PI
  • Cyrus KumpExecutive Officer, DirectorNamed in SEC Form D filings
  • David Max GuillotDirectorNamed in SEC Form D filings

What it has protected

No granted patents are on record.

USPTO usually publishes applications 18 months after filing, so recent applications may not be visible yet. Patents assigned under a different entity name won’t match.

Checked: USPTO granted patents and published applications · Oct 23, 2026

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .